{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:08:49Z","timestamp":1780466929381,"version":"3.54.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010571","name":"Bundesministerium f\u00fcr Bildung, Wissenschaft, Forschung und Technologie","doi-asserted-by":"publisher","award":["TRACK, #01KD25030"],"award-info":[{"award-number":["TRACK, #01KD25030"]}],"id":[{"id":"10.13039\/501100010571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010571","name":"Bundesministerium f\u00fcr Bildung, Wissenschaft, Forschung und Technologie","doi-asserted-by":"publisher","award":["CAMINO, #01EO2101"],"award-info":[{"award-number":["CAMINO, #01EO2101"]}],"id":[{"id":"10.13039\/501100010571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002957","name":"Technische Universit\u00e4t Dresden","doi-asserted-by":"publisher","award":["MeDDrive #60534"],"award-info":[{"award-number":["MeDDrive #60534"]}],"id":[{"id":"10.13039\/501100002957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41375-026-02961-y","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:15:15Z","timestamp":1775650515000},"page":"1327-1330","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2687-9178","authenticated-orcid":false,"given":"Jonas","family":"Schadt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"von Bonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-437X","authenticated-orcid":false,"given":"Uta","family":"Oelschl\u00e4gel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Teipel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Epp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4095-8649","authenticated-orcid":false,"given":"Felix Carl","family":"Saalfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freya","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Heuschkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5916-3029","authenticated-orcid":false,"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8213-2047","authenticated-orcid":false,"given":"Maximilian Alexander","family":"R\u00f6hnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"2961_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1056\/NEJMoa2203478","volume":"387","author":"P Moreau","year":"2022","unstructured":"Moreau P, Garfall AL, Van De Donk NWCJ, Nahi H, San-Miguel JF, Oriol A, et al. Teclistamab in relapsed or refractory multiple myeloma. N Engl J Med. 2022;387:495\u2013505.","journal-title":"N Engl J Med"},{"key":"2961_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01191-8","volume":"14","author":"D Swan","year":"2024","unstructured":"Swan D, Madduri D, Hocking J. CAR-T cell therapy in multiple myeloma: current status and future challenges. Blood Cancer J. 2024;14:206.","journal-title":"Blood Cancer J"},{"key":"2961_CR3","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1016\/j.ymthe.2017.07.004","volume":"25","author":"JN Kochenderfer","year":"2017","unstructured":"Kochenderfer JN, Somerville RPT, Lu T, Yang JC, Sherry RM, Feldman SA, et al. Long-duration complete remissions of diffuse large B-cell lymphoma after anti-CD19 chimeric antigen receptor T cell therapy. Mol Ther. 2017;25:2245\u201353.","journal-title":"Mol Ther"},{"key":"2961_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.830773","volume":"13","author":"A Peinelt","year":"2022","unstructured":"Peinelt A, Bremm M, Kreyenberg H, Cappel C, Banisharif-Dehkordi J, Erben S, et al. Monitoring of circulating CAR T cells: validation of a flow cytometric assay, cellular kinetics, and phenotype analysis following tisagenlecleucel. Front Immunol. 2022;13:830773.","journal-title":"Front Immunol"},{"key":"2961_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.annonc.2021.12.003","volume":"33","author":"PJ Hayden","year":"2022","unstructured":"Hayden PJ, Roddie C, Bader P, Basak GW, Bonig H, Bonini C, et al. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Ann Oncol. 2022;33:259\u201375.","journal-title":"Ann Oncol"},{"key":"2961_CR6","first-page":"306.e1","volume":"30","author":"I De La Iglesia-San Sebasti\u00e1n","year":"2024","unstructured":"De La Iglesia-San Sebasti\u00e1n I, Carbonell D, Bastos-Oreiro M, P\u00e9rez-Corral A, Bail\u00e9n R, Chicano M, et al. Digital PCR improves sensitivity and quantification in monitoring CAR-T cells in B-cell lymphoma patients. Transpl Cell Ther. 2024;30:306.e1\u2013306.e12.","journal-title":"Transpl Cell Ther"},{"key":"2961_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/cyto.b.21941","volume":"100","author":"J Demaret","year":"2021","unstructured":"Demaret J, Varlet P, Trauet J, Beauvais D, Grossemy A, H\u00e9go F, et al. Monitoring CAR T-cells using flow cytometry. Cytom B Clin Cytom. 2021;100:218\u201324.","journal-title":"Cytom B Clin Cytom"},{"key":"2961_CR8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/cyto.a.24825","volume":"105","author":"JL Valdivieso-Shephard","year":"2024","unstructured":"Valdivieso-Shephard JL, Matas-P\u00e9rez E, Garc\u00eda-Bujalance S, Mirones-Aguilar I, Gonz\u00e1lez-Mart\u00ednez B, P\u00e9rez-Mart\u00ednez A, et al. The challenge of standardizing CAR-T cell monitoring: a comparison of two flow-cytometry methods and correlation with qPCR technique. Cytom A. 2024;105:368\u201375.","journal-title":"Cytom A"},{"key":"2961_CR9","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1182\/bloodadvances.2023009714","volume":"7","author":"B Glatte","year":"2023","unstructured":"Glatte B, Wenk K, Grahnert A, Friedrich M, Merz M, Vucinic V, et al. Teclistamab impairs detection of BCMA CAR-T cells. Blood Adv. 2023;7:3842\u20135.","journal-title":"Blood Adv"},{"key":"2961_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13717","volume":"17","author":"Y Guo","year":"2024","unstructured":"Guo Y, Quijano Card\u00e9 NA, Kang L, Verona R, Banerjee A, Kobos R, et al. Teclistamab: mechanism of action, clinical, and translational science. Clin Transl Sci. 2024;17:e13717.","journal-title":"Clin Transl Sci"},{"key":"2961_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11523-023-00989-z","volume":"18","author":"X Miao","year":"2023","unstructured":"Miao X, Wu LS, Lin SXW, Xu Y, Chen Y, Iwaki Y, et al. Population pharmacokinetics and exposure\u2013response with teclistamab in patients with relapsed\/refractory multiple myeloma: results from MajesTEC-1. Target Oncol. 2023;18:667\u201384.","journal-title":"Target Oncol"},{"key":"2961_CR12","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3390\/biomedicines12081641","volume":"12","author":"A Grahnert","year":"2024","unstructured":"Grahnert A, Seiffert S, Wenk K, Schmiedel D, Boldt A, Vucinic V, et al. Evaluation of Anti-CAR linker mAbs for CAR T monitoring after BiTEs\/bsAbs and CAR T-cell pretreatment. Biomedicines. 2024;12:1641.","journal-title":"Biomedicines"},{"key":"2961_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-29","volume":"10","author":"Z Zheng","year":"2012","unstructured":"Zheng Z, Chinnasamy N, Morgan RA. Protein L: a novel reagent for the detection of chimeric antigen receptor (CAR) expression by flow cytometry. J Transl Med. 2012;10:29.","journal-title":"J Transl Med"},{"key":"2961_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1089\/hum.2018.001","volume":"29","author":"KM Friedman","year":"2018","unstructured":"Friedman KM, Garrett TE, Evans JW, Horton HM, Latimer HJ, Seidel SL, et al. Effective targeting of Multiple B-cell maturation antigen\u2013expressing hematological malignances by anti-B-cell maturation antigen chimeric antigen receptor T cells. Hum Gene Ther. 2018;29:585\u2013601.","journal-title":"Hum Gene Ther"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02961-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02961-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02961-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:43:30Z","timestamp":1780465410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02961-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2961"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-02961-y","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JS got research funding from TUD Dresden University of Technology (MeDDrive #60534). JS and MAR got a joint research grant from the German Federal Ministry of Research, Technology and Space (TRACK, #01KD25030). MvB was funded by the German Federal Ministry of Research, Technology and Space (CAMINO, #01EO2101). FCS received honoraria from Bristol Myers Squibb, Johnson & Johnson, and Pfizer. Although these companies are active in the field of CAR-T cell therapy and bispecific antibodies, these payments were not related to the present work. All other authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The trial was approved by the institutional review board at TUD Dresden University of Technology (IRB00001473, reference number BO-EK-66022024), and informed consent was obtained from all participants. All procedures involving patients or patient data were performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}